Valuation: Old API Wind-down Ltd.

Market Cap 87.35K 75.41K 70.75K 64.44K 121K 8.35M 123K 829K 325K 4.18M 328K 321K 13.92M P/E 2016
-2.53x
P/E 2017 -0.75x
Enterprise Value 246M 212M 199M 181M 341M 23.5B 346M 2.33B 914M 11.77B 923M 903M 39.16B EV / Sales 2016
9.18x
EV / Sales 2017 3.22x
Free-Float
100%
Yield 2016 *
-
Yield 2017 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
+2.54%-0.85%+72.59%+120.47% 1,055B
+2.76%+3.88%+53.12%+56.46% 632B
+2.56%+2.43%+24.01%+70.61% 442B
+0.93%-2.39%+40.66%+41.19% 351B
+1.57%-0.38%+25.10%+40.26% 290B
+1.71%-0.66%+0.24%+10.40% 243B
+1.23%+2.26%+44.79%+61.82% 227B
+0.96%-4.38%-15.47%-53.05% 200B
+2.09%+3.42%+19.00%+85.04% 172B
Average +1.61%-1.30%+29.34%+48.13% 361.25B
Weighted average by Cap. +2.03%-1.87%+42.27%+66.62%

Financials

2016 2017
Net sales 54.27M 46.85M 43.95M 40.03M 75.28M 5.19B 76.32M 515M 202M 2.6B 204M 199M 8.65B 106M 91.46M 85.81M 78.15M 147M 10.13B 149M 1.01B 394M 5.08B 398M 389M 16.88B
Net income -103M -88.9M -83.4M -75.96M -143M -9.85B -145M -978M -383M -4.93B -387M -378M -16.41B -125M -108M -101M -92.36M -174M -11.97B -176M -1.19B -466M -6B -470M -460M -19.95B
Net Debt 209M 181M 170M 155M 291M 20.03B 295M 1.99B 779M 10.04B 787M 770M 33.38B 246M 212M 199M 181M 341M 23.49B 345M 2.33B 914M 11.77B 922M 902M 39.14B
Logo Old API Wind-down Ltd.
Old API Wind-Down Ltd, formerly Aralez Pharmaceuticals Inc., is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company's products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G. Its development products include YOSPRALA and Bilastine. Fibricor (fenofibric acid) is indicated as a complementary therapy along with diet for the treatment of hypertriglyceridemia, and as a complementary therapy along with diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), triglycerides (TG) and apolipoprotein B (Apo B). Fibricor is also used to increase high-density lipoprotein (HDL) cholesterol (HDL-C) in patients with hypercholesterolemia or mixed dyslipidemia. Cambia (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug (NSAID).
Employees
-
  1. Stock Market
  2. Stocks
  3. ARLZQ Stock